Advanced Search

National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 6) (PB 79 of 2015)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
PB 79 of 2015
National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 6)
National Health Act 1953
I, KYLIE JONASSON, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated                                          25 August 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KYLIE JONASSON
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 6).
            (2)        This Instrument may also be cited as PB 79 of 2015.
2          Commencement
            This Instrument commences on 1 September 2015.
3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1     Amendments
 
[1] Schedule 1, omit entry for Lactulose
[2] Schedule 1, entry for Metformin in the form Tablet (extended release) containing metformin hydrochloride 500 mg
omit from the column headed “Claimed Price”:          6.51        substitute:             7.12
[3] Schedule 1, entry for Nitrazepam
omit from the column headed “Claimed Price”:          2.29        substitute:             2.65